mTOR-mediated differentiation and maintenance of suppressive T cells at the center stage of IPEX treatment

Immunol Res. 2024 Mar 11. doi: 10.1007/s12026-024-09472-x. Online ahead of print.
No abstract available

Publication types

  • Letter